BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18423147)

  • 1. [A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
    Song HL; Shen ZY; Wang J; Zheng WP; Wang ZL
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):265-9. PubMed ID: 18423147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis.
    Ghany MG; Ayola B; Villamil FG; Gish RG; Rojter S; Vierling JM; Lok AS
    Hepatology; 1998 Jan; 27(1):213-22. PubMed ID: 9425940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis B patient with hepatitis B surface antigen loss during lamivudine therapy.
    Lee SY; Choi MS; Lee D; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2005 Jun; 20(3):433-7. PubMed ID: 15953865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
    Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
    Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
    Kim KH; Lee KH; Chang HY; Ahn SH; Tong S; Yoon YJ; Seong BL; Kim SI; Han KH
    J Med Virol; 2003 Nov; 71(3):367-75. PubMed ID: 12966541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
    Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
    Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic alterations in the S gene of hepatitis B virus in patients with acute hepatitis B, chronic hepatitis B and hepatitis B liver cirrhosis before and after liver transplantation.
    Rodriguez-Frias F; Buti M; Jardi R; Vargas V; Quer J; Cotrina M; Martell M; Esteban R; Guardia J
    Liver; 1999 Jun; 19(3):177-82. PubMed ID: 10395035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis.
    Akyildiz M; Karasu Z; Zeytunlu M; Aydin U; Ozacar T; Kilic M
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2130-4. PubMed ID: 18031370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis.
    Carman WF; Trautwein C; van Deursen FJ; Colman K; Dornan E; McIntyre G; Waters J; Kliem V; Müller R; Thomas HC; Manns MP
    Hepatology; 1996 Sep; 24(3):489-93. PubMed ID: 8781312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamivudine and low-dose hepatitis B immune globulin for prophylaxis of hepatitis B reinfection after liver transplantation possible role of mutations in the YMDD motif prior to transplantation as a risk factor for reinfection.
    Rosenau J; Bahr MJ; Tillmann HL; Trautwein C; Klempnauer J; Manns MP; Böker KHW
    J Hepatol; 2001 Jun; 34(6):895-902. PubMed ID: 11451174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
    Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
    Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-naïve and lamivudine-treated patients with chronic hepatitis B.
    Ding H; Liu B; Zhao C; Yang J; Yan C; Yan L; Zhuang H; Li T
    Antiviral Res; 2014 Feb; 102():29-34. PubMed ID: 24316031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus.
    Wakil SM; Kazim SN; Khan LA; Raisuddin S; Parvez MK; Guptan RC; Thakur V; Hasnain SE; Sarin SK
    J Med Virol; 2002 Nov; 68(3):311-8. PubMed ID: 12226816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation.
    Tillmann HL; Trautwein C; Bock T; Böker KH; Jäckel E; Glowienka M; Oldhafer K; Bruns I; Gauthier J; Condreay LD; Raab HR; Manns MP
    Hepatology; 1999 Jul; 30(1):244-56. PubMed ID: 10385663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of S gene mutation of the hepatitis B virus in adult liver transplant recipients showing resistance to hepatitis B immunoglobulin therapy.
    Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Shin YW; Kim SH; Chang KH; Namgoong JM; Park CS; Park HW; Park YH; Kang SH; Jung BH; Lee SG
    Transplant Proc; 2013 Oct; 45(8):3047-51. PubMed ID: 24157033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of naturally occurring and Lamivudine-induced surface gene mutants of hepatitis B virus in patients with chronic hepatitis B in India.
    Kazim SN; Sarin SK; Sharma BC; Khan LA; Hasnain SE
    Intervirology; 2006; 49(3):152-60. PubMed ID: 16428891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variations in the S and P regions of the hepatitis B virus genome under immunosuppression in vitro and in vivo.
    Shen ZY; Zheng WP; Deng YL; Song HL
    Viral Immunol; 2012 Oct; 25(5):368-78. PubMed ID: 22946668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients.
    Urabe A; Imamura M; Tsuge M; Kan H; Fujino H; Fukuhara T; Masaki K; Kobayashi T; Ono A; Nakahara T; Kawaoka T; Hiramatsu A; Kawakami Y; Aikata H; Hayes CN; Maki N; Ohdan H; Chayama K
    J Gastroenterol; 2017 Mar; 52(3):366-375. PubMed ID: 27422771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.